| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 2,294 | 3,000 | 0.00% | ||
| 2 | ASTERIAS BIOTHERAPEUTICS INC COM SER A | 1,875 | 7,000 | 0.00% | ||
| 3 | CELLADON CORP | 50,000 | 74,000 | 0.01% | ||
| 4 | Theravance Biopharma Inc | 11,428 | 187,000 | 0.03% | ||
| 5 | GERON CORP | 45,000 | 218,000 | 0.03% | ||
| 6 | TETRAPHASE PHARMACEUTICALS INC COM | 22,000 | 221,000 | 0.03% | ||
| 7 | Heartware International, Inc. | 5,000 | 252,000 | 0.04% | ||
| 8 | XOMA CORP DEL | 225,000 | 299,000 | 0.05% | ||
| 9 | TENET HEALTHCARE CORP | 10,000 | 303,000 | 0.05% | ||
| 10 | ENDOCYTE INC | 100,000 | 401,000 | 0.06% | ||
| 11 | IMMUNOGEN INC | 30,000 | 407,000 | 0.06% | ||
| 12 | MANNKIND CORP. | 300,000 | 435,000 | 0.07% | ||
| 13 | CARDIOVASCULAR SYS INC DEL COM | 30,000 | 454,000 | 0.07% | ||
| 14 | Juniper Pharmaceuticals Inc | 50,000 | 515,000 | 0.08% | ||
| 15 | ARBUTUS BIOPHARMA CORP | 125,000 | 556,000 | 0.08% | ||
| 16 | MYRIAD GENETICS INC | 14,000 | 604,000 | 0.09% | ||
| 17 | TEAM HEALTH HOLDINGS INC | 15,000 | 658,000 | 0.10% | ||
| 18 | IMPAX LABORATORIES INC | 18,000 | 770,000 | 0.12% | ||
| 19 | INSULET CORPORATION | 21,000 | 794,000 | 0.12% | ||
| 20 | RESMED INC | 15,000 | 805,000 | 0.12% | ||
| 21 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 80,000 | 807,000 | 0.12% | ||
| 22 | ISHARES TR | 2,500 | 846,000 | 0.13% | ||
| 23 | KITE PHARMA INCORPORATED | 14,000 | 863,000 | 0.13% | ||
| 24 | ABBVIE INC | 15,000 | 889,000 | 0.14% | ||
| 25 | Esperion Therapeutics Inc | 40,000 | 890,000 | 0.14% | ||
| 26 | EXELIXIS INC | 170,000 | 959,000 | 0.15% | ||
| 27 | ALDER BIOPHARMACEUTICALS INC | 33,000 | 1,090,000 | 0.17% | ||
| 28 | ULTRAGENYX PHARMACEUTICAL INC COM | 10,000 | 1,122,000 | 0.17% | ||
| 29 | ANGIODYNAMICS INC | 100,000 | 1,214,000 | 0.18% | ||
| 30 | LABORATORY CORP AMER HLDGS | 10,000 | 1,236,000 | 0.19% | ||
| 31 | INFINITY PHARMACEUTICALS INC | 160,000 | 1,256,000 | 0.19% | ||
| 32 | DAVITA INC | 20,000 | 1,394,000 | 0.21% | ||
| 33 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,456,000 | 0.22% | ||
| 34 | WELLCARE HEALTH PLANS INC | 20,000 | 1,564,000 | 0.24% | ||
| 35 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,604,000 | 0.24% | ||
| 36 | JUNO THERAPEUTICS INC COM | 37,000 | 1,627,000 | 0.25% | ||
| 37 | Wright Medical Group NV | 70,309 | 1,700,000 | 0.26% | ||
| 38 | INOVIO PHARMACEUTICALS INC | 265,000 | 1,781,000 | 0.27% | ||
| 39 | PTC THERAPEUTICS INC | 55,000 | 1,782,000 | 0.27% | ||
| 40 | STERICYCLE INC | 15,000 | 1,809,000 | 0.28% | ||
| 41 | CLOVIS ONCOLOGY INC | 52,500 | 1,838,000 | 0.28% | ||
| 42 | BLUEBIRD BIO INC COM | 29,000 | 1,862,000 | 0.28% | ||
| 43 | INTERCEPT PHARMACEUTICALS INCORPORATED | 13,500 | 2,016,000 | 0.31% | ||
| 44 | PROTHENA CORP PLC | 31,000 | 2,111,000 | 0.32% | ||
| 45 | ZELTIQ AESTHETICS INC | 75,000 | 2,140,000 | 0.33% | ||
| 46 | ALNYLAM PHARMACEUTICALS INC | 24,000 | 2,259,000 | 0.34% | ||
| 47 | HEALTHCARE SVCS GRP INC | 65,000 | 2,267,000 | 0.35% | ||
| 48 | NUVASIVE INC | 45,000 | 2,435,000 | 0.37% | ||
| 49 | TELEFLEX INC | 18,557 | 2,439,000 | 0.37% | ||
| 50 | GLOBUS MED INC | 87,700 | 2,440,000 | 0.37% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-014462, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
